Peptilogics
PrivateLast Round
Series B
Extension
Oct 16, 2025
Est. Valuation
$420M
Total Funding Raised
$135.67M
Company Overview
Peptilogics is a biotechnology company that develops novel peptide therapeutics using an AI-powered drug discovery platform to treat multidrug-resistant bacterial infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Peptilogics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Peptilogics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Oct 16, 2025 | ||||
| Grant | Jan 9, 2025 | ||||
| Series B | Dec 21, 2020 | ||||
| Grant | Feb 25, 2020 | ||||
| Series A | Sep 29, 2017 | ||||
Seed | Oct 21, 2016 |
Key People
Founding team and executive leadership
Peptilogics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pittsburgh Life Sciences Greenhouse | Seed |
| Narya Capital | Series B Extension |
| AMR Action Fund | Series B Extension |
| BlueTree Allied Angels | Series A |
| CARB-X | Grant |
| Beyond Ventures | Series B Extension |
| Pathfinder Venture Capital | Series B, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 9, 2025
Secured $3.3M in grant funding.
Peptilogics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Peptilogics's valuation, stock price, and market status.